GI
LGND icon

GAMMA Investing’s Ligand Pharmaceuticals LGND Stock Holding History

GAMMA Investing’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
681
+37
+6% +$8.72K 0.01% 1223
2026
Q1 		$129K Buy
644
+17
+3% +$3.36K 0.01% 1464
2025
Q4 		$119K Buy
627
+52
+9% +$9.99K 0.01% 1454
2025
Q3 		$102K Buy
575
+63
+12% +$9.37K 0.01% 1502
2025
Q2 		$58.2K Sell
512
-81
-14% -$8.66K ﹤0.01% 1830
2025
Q1 		$62.3K Buy
593
+241
+68% +$27.3K ﹤0.01% 1635
2024
Q4 		$37.7K Buy
352
+56
+19% +$6.33K ﹤0.01% 1876
2024
Q3 		$29.6K Buy
296
+91
+44% +$9.16K ﹤0.01% 1855
2024
Q2 		$17.3K Buy
205
+44
+27% +$3.5K ﹤0.01% 1944
2024
Q1 		$11.8K Sell
161
-68
-30% -$5.01K ﹤0.01% 1971
2023
Q4 		$16.7K Buy
+229
New +$13.5K ﹤0.01% 1614

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
PWG
Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

GAMMA Investing's LGND Position: Q2 2026 in Review

GAMMA Investing increased its Ligand Pharmaceuticals (LGND) stake by 5.7% in Q2 2026, buying an estimated $8.72K and bringing the position to 681 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #1223.

GAMMA Investing first reported a position in LGND in Q4 2023 and has held it in 11 quarters since. 36 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • GAMMA Investing held 681 shares of Ligand Pharmaceuticals worth $215K as of Q2 2026.
  • GAMMA Investing bought 37 Ligand Pharmaceuticals shares in Q2 2026, an estimated $8.72K.
  • Ligand Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1223 holding.
  • GAMMA Investing first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 36 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.